FDA.reportPublic FDA data

Meclizine Chewable Tablets

Manufacturer
Pharmasource Meds, LLC
Effective date
2024-05-28
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-01 21:01:49

Label at a glance#

ProductMeclizine Hydrochloride
Active ingredientMECLIZINE HYDROCHLORIDE
Label structure10 sections

Indications and uses

prevents and treats nausea, vomiting or dizziness due to motion sickness

Dosage and administration

 Dosage should be taken one hour before travel starts adults and children 12 years of age and over chew 1 to 2 tablets once daily, or as directed by a doctor children under 12 years of age do not give this product to children under 12 years of age unless directed by a doctor

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each chewable tablet)
Meclizine HCl 25 mg

OTC - PURPOSE SECTION

Purpose

Antiemetic

Uses

INDICATIONS & USAGE SECTION

prevents and treats nausea, vomiting or dizziness due to motion sickness

WARNINGS SECTION

Do not use in

OTC - DO NOT USE SECTION

children under 12 years of age unless directed by a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

 glaucoma

 a breathing problem such as emphysema or chronic bronchitis
 trouble urinating due to an enlarged prostate gland

Ask a doctor or pharmacist before use if

OTC - ASK DOCTOR/PHARMACIST SECTION

you are taking sedatives or tranquilizers

When using this product

OTC - WHEN USING SECTION

 Do not exceed recommended dosage

 may cause drowsiness

 alcohol, sedatives, and tranquilizers may increase drowsiness

 avoid alcoholic drinks
 use caution when driving a motor vehicle or operating machinery

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

OVERDOSAGE SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

 Dosage should be taken one hour before travel starts

adults and children 12
years of age and over 		chew 1 to 2 tablets once daily, or as directed by a doctor
children under
12 years of age 		do not give this product to children under 12 years of age
unless directed by a doctor

Other information

OTHER SAFETY INFORMATION

 Store in a dry place at 15°-30°C (59°-86°F)
 keep lid tightly closed

INACTIVE INGREDIENT SECTION

Croscarmellose Sodium, Crospovidone, FD&C Red #40 Lake, French Vanilla Flavor, Lactose, Magnesium Stearate, Raspberry Flavor, Silica, Sodium Saccharin, Stearic Acid

Questions or comments?

OTC - QUESTIONS SECTION

1-800-645-2158

SPL UNCLASSIFIED SECTION

TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

*This product is not manufactured or distributed by Wellspring Pharmaceutical Corporation, owner of the registered trademark Bonine®.

Distributed by:

RUGBY® LABORATORIES

Indianapolis, IN 46268

Please reference the "Other information" section listed above for storage information. This drug product has been received by Pharmasource Meds, LLC in a manufacturer or distributor packaged configuration and repackaged in full compliance with all applicable GMP regulations. The drug product is repackaged and labeled for single patient use to be dispensed within a pharmacy setting as a single patient prescription.


www.rugbylaboratories.com

Repackaged by:
Pharmasource Meds, LLC
Tigard, OR 97223

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC: 82982-036-30
Meclizine USP
Chewable Tablets
25 mg

Repackaged for RxOnly settings
30 Chewable Tablets
Pharmasource Meds, LLC

meclizine labelmeclizine label

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0536-1299-10EA - Each0536-12994be88e27-d239-44c2-93e3-eb1867badd8212021-02-05

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82982-03682982-036-30
0536-1299

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Name, UNII, Kind table
NameUNIIKind
CROSPOVIDONE2S7830E561IACT
VANILLAQ74T35078HIACT
MAGNESIUM STEARATE70097M6I30IACT
RASPBERRY4N14V5R27WIACT
STEARIC ACID4ELV7Z65APIACT
SILICON DIOXIDEETJ7Z6XBU4IACT
FD&C RED NO. 40WZB9127XOAIACT
LACTOSE MONOHYDRATEEWQ57Q8I5XIACT
SACCHARIN SODIUMSB8ZUX40TYIACT
CROSCARMELLOSE SODIUMM28OL1HH48IACT
MECLIZINE HYDROCHLORIDEHDP7W44CIOACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Meclizine HydrochlorideMECLIZINE HYDROCHLORIDERugby Laboratoriesb57f14a7-3852-03db-e053-2a95a90a80d62026-07-16WarningsExact identifier
ndc (product): 0536-1299
198bf1bf-cd7f-85c1-e063-6294a90a8c16f9568e8c-4ba1-b37b-e053-6294a90a02402024-05-28WarningsExact identifier
spl id: 198bf1bf-cd7f-85c1-e063-6294a90a8c16
spl set id: f9568e8c-4ba1-b37b-e053-6294a90a0240

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.